| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004466543 |
| P356 | DOI | 10.1038/SJ.KI.5001517 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/sj.ki.5001517 |
| P698 | PubMed publication ID | 16688115 |
| P50 | author | Marianne Fillet | Q55510280 |
| P2093 | author name string | Li N | |
| Renert AF | |||
| Li PL | |||
| Yi F | |||
| Zhang AY | |||
| Muh RW | |||
| P2860 | cites work | Identification of renox, an NAD(P)H oxidase in kidney | Q22254385 |
| Novel Human Homologues of p47 and p67 Participate in Activation of Superoxide-producing NADPH Oxidases | Q24300616 | ||
| The response-to-retention hypothesis of early atherogenesis | Q24629974 | ||
| Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death | Q28213775 | ||
| Homocysteine enhances TIMP-1 expression and cell proliferation associated with NADH oxidase in rat mesangial cells | Q28565638 | ||
| Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension | Q30080036 | ||
| The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases | Q30824712 | ||
| Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications. | Q33596089 | ||
| Apoptotic mechanisms in acute renal failure | Q33887907 | ||
| Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology | Q34059645 | ||
| Current molecular models for NADPH oxidase regulation by Rac GTPase | Q34915029 | ||
| Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis | Q35904374 | ||
| Vascular NADPH oxidases: molecular mechanisms of activation. | Q35994483 | ||
| Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes | Q41521919 | ||
| Hyperhomocysteinemia: detection, risk assessment, and treatment | Q41609218 | ||
| Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism | Q41829734 | ||
| Cytoskeletal rearrangement and signal transduction in TGF-beta1-stimulated mesangial cell collagen accumulation | Q42444937 | ||
| Increased uracil misincorporation in lymphocytes from folate-deficient rats | Q43202408 | ||
| Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension | Q43908215 | ||
| Separation, identification and quantitation of ceramides in human cancer cells by liquid chromatography-electrospray ionization tandem mass spectrometry. | Q43985878 | ||
| Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function | Q44123762 | ||
| Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries | Q44210993 | ||
| Chronic methionine load-induced hyperhomocysteinemia enhances rat carotid responsiveness for angiotensin II. | Q44699239 | ||
| Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells | Q45116558 | ||
| Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice | Q45182276 | ||
| Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. | Q50139335 | ||
| Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. | Q51574125 | ||
| Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study | Q51589425 | ||
| Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1 | Q59053220 | ||
| Atherosclerosis, serum cholesterol and the homocysteine theory: a study of 194 consecutive autopsies | Q68745484 | ||
| Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation | Q71743133 | ||
| Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis | Q73089674 | ||
| Responses of vascular smooth muscle cell to extracellular matrix degradation | Q73119209 | ||
| Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney | Q73555562 | ||
| Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats | Q73704615 | ||
| Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans | Q78253221 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ceramides | Q424213 |
| P304 | page(s) | 88-96 | |
| P577 | publication date | 2006-05-10 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats | |
| P478 | volume | 70 |
| Q92194987 | A risk scoring system for the decreased glomerular filtration rate in Chinese general population |
| Q35474438 | Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice |
| Q34425178 | Acid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-β-synthase |
| Q37121306 | Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia |
| Q35835781 | Association of homocysteine with type 1 diabetes mellitus: a meta-analysis |
| Q24630011 | Ceramide: a common pathway for atherosclerosis? |
| Q34937098 | Contribution of NADPH oxidase to membrane CD38 internalization and activation in coronary arterial myocytes |
| Q37622159 | Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia |
| Q45052622 | Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia |
| Q37151470 | Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats |
| Q30641163 | Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation |
| Q36941304 | Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage |
| Q34501679 | Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation |
| Q92650058 | Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration |
| Q35821693 | Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia |
| Q35080666 | Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling |
| Q37118990 | Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury |
| Q64931066 | Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis. |
| Q33969606 | Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes |
| Q26740414 | Homocysteine in Renal Injury |
| Q37298478 | Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure |
| Q36265878 | Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults |
| Q35723477 | Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis |
| Q38931056 | Inflammasome Activation in Chronic Glomerular Diseases |
| Q37109925 | Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene |
| Q35724538 | Long-term methionine-diet induced mild hyperhomocysteinemia associated cardiac metabolic dysfunction in multiparous rats. |
| Q95322549 | Low doses of folic acid can reduce hyperhomocysteinemia-induced glomerular injury in spontaneously hypertensive rats |
| Q33646673 | Mechanisms of homocysteine-induced glomerular injury and sclerosis |
| Q34381598 | Methylenetetrahydrofolate reductase C677T polymorphism is associated with estimated glomerular filtration rate in hypertensive Chinese males |
| Q36731427 | NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia |
| Q34222583 | NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats |
| Q33721868 | New insights into TRP channels: Interaction with pattern recognition receptors |
| Q34245112 | Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia |
| Q47877023 | Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis |
| Q37784045 | Oxidative stress in obstructive nephropathy |
| Q89920236 | Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases |
| Q33729668 | Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene |
| Q37121300 | Regulation of renin release via cyclic ADP-ribose-mediated signaling: evidence from mice lacking CD38 gene |
| Q35564803 | Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes |
| Q34574599 | Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats |
| Q28074668 | Role of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An Update |
| Q49399657 | Translational Aspects of Sphingolipid Metabolism in Renal Disorders. |
Search more.